Just In
HUL shares rise 2% to ₹2,484.90 on NSE after strong profit performance
HUL's total income rose by 5% year-on-year to ₹16,715 crore in Q1FY26
HUL consolidated net profit surges 5.96% to ₹2,768 crore in Q1FY26
HUL shares rise 2% to ₹2,484.90 on NSE after strong profit performance
HUL's total income rose by 5% year-on-year to ₹16,715 crore in Q1FY26
HUL consolidated net profit surges 5.96% to ₹2,768 crore in Q1FY26

pharma industry

(8 search results)

Nandini Piramal charts bold growth path: Piramal Pharma eyes $2 billion revenue by FY30
Innovation-led Indian healthcare market to hit $320 bn by FY28: Bain
Laurus Injects Tech In Pharma

Laurus Injects Tech In Pharma

Budget 2023 may offer Research Linked Incentive scheme for Indian pharma
Surprise! Despite Covid-19 sales, Indian pharma an underperformer
Sluggish exports to hit pharma revenue growth: CRISIL
Predictions 2022: Year of personalisation of healthcare and therapies
Predictions 2022: The pandemic and beyond: How the pharma industry is shaping up for the future